Expression of neural receptors in mouse meibomian gland

Cornea

Volumn 29, Issue 7, 2010, Pages 794-801

  Zhu, Hong Yuan ^a,b   Riau, Andri K ^a,b   Barathi, V A ^a   Chew, Jaime ^a   Beuerman, Roger W ^a,b,c  

^a SINGAPORE EYE RESEARCH INSTITUTE   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

meibomian gland; muscarinic cholinergic receptor; nerve; neuropeptide Y; substance P; vasoactive intestinal peptide

Indexed keywords

MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; MUSCARINIC M5 RECEPTOR; MUSCARINIC RECEPTOR; NEUROPEPTIDE Y RECEPTOR; RNA; SUBSTANCE P RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR; MESSENGER RNA; NEUROKININ 1 RECEPTOR; NEUROPEPTIDE Y-Y1 RECEPTOR; VASOACTIVE INTESTINAL POLYPEPTIDE RECEPTOR 1;

ACINAR CELL; ANIMAL CELL; ANIMAL TISSUE; ANTIBODY LABELING; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; EYELID; FROZEN SECTION; GENE EXPRESSION; LASER CAPTURE MICRODISSECTION; MEIBOMIAN GLAND; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; POLYMERASE CHAIN REACTION;

ANIMALS; BLOTTING, WESTERN; EYELIDS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; MEIBOMIAN GLANDS; MICE; MICE, INBRED BALB C; POLYMERASE CHAIN REACTION; RECEPTORS, MUSCARINIC; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROPEPTIDE Y; RECEPTORS, VASOACTIVE INTESTINAL POLYPEPTIDE, TYPE I; RNA, MESSENGER;

EID: 77954425047     PISSN: 02773740     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICO.0b013e3181ca3262     Document Type: Article

References (68)

1. Dartt DA. Dysfunctional neural regulation of lacrimal gland secretion and its role in the pathogenesis of dry eye syndromes. Ocul Surf. 2004;2:76-91.
2. Bron AJ, Benjamin L, Snibson GR. Meibomian gland disease. Classification and grading of lid changes. Eye. 1991;5:395-411.
3. Mathers WD. Ocular evaporation in meibomian gland dysfunction and dry eye. Ophthalmology. 1993;100:347-351.
4. Mathers WD, Shields WJ, Sachdev MS, et al. Meibomian gland dysfunction in chronic blepharitis. Cornea. 1991;10:277-285.
5. Bron A, Tripathi R, Tripathi B. Wolff's Anatomy of the Eye and Orbit. London, United Kingdom: Chapman & Hall; 1997. pp. 30-84.
6. Tiffany JM. The role of meibomian secretion in the tears. Trans Ophthalmol Soc U K. 1985;104:396-401.
7. Jester JV, Nicolaides N, Smith RE. Meibomian gland studies: histologic and ultrastructural investigations. Invest Ophthalmol Vis Sci. 1981;20: 537-547. (Pubitemid 11007358)
8. Kirch W, Horneber M, Tamm ER. Characterization of Meibomian gland innervation in the cynomolgus monkey (Macaca fascicularis). Anat Embryol (Berl). 1996;193:365-375.
9. Chung CW, Tigges M, Stone RA. Peptidergic innervation of the primate meibomian gland. Invest Ophthalmol Vis Sci. 1996;37:238-245. (Pubitemid 26036536)
10. Seifert P, Spitznas M. Vasoactive intestinal polypeptide (VIP) innervation of the human eyelid glands. Exp Eye Res. 1999;68:685-692. (Pubitemid 29290788)
11. Simons E, Smith PG. Sensory and autonomic innervation of the rat eyelid: neuronal origins and peptide phenotypes. J Chem Neuroanat. 1994;7: 35-47. (Pubitemid 24271593)
12. Miraglia T, Gomes NF. The meibomian glands of the marmoset (Callithrix jacchus). Acta Anat. 1969;74:104-113.
13. Datar P, Srivastava S, Coutinho E, et al. Substance P: structure, function, and therapeutics. Curr Top Med Chem. 2004;4:75-103. (Pubitemid 38849358)
14. Lecci A, Maggi CA. Peripheral tachykinin receptors as potential therapeutic targets in visceral diseases. Expert Opin Ther Targets. 2003;7:343-362. (Pubitemid 36722220)
15. Patacchini R, Maggi CA. Peripheral tachykinin receptors as targets for new drugs. Eur J Pharmacol. 2001;429:13-21. (Pubitemid 33043978)
16. Lecci A, Giuliani S, Tramontana M, et al. Peripheral actions of tachykinins. Neuropeptides. 2000;34:303-313.
17. Duffy RA. Potential therapeutic targets for neurokinin-1 receptor antagonists. Expert Opin Emerg Drugs. 2004;9:9-21. (Pubitemid 38715575)
18. Alvaro G, Di Fabio R. Neurokinin 1 receptor antagonists\current prospects. Curr Opin Drug Discov Devel. 2007;10:613-621.
19. Moody TW, Gozes I. Vasoactive intestinal peptide receptors: a molecular target in breast and lung cancer. Curr Pharm Des. 2007;13:1099-1104. (Pubitemid 46739339)
20. Liu S, Li J, Beuerman RW, et al. The eyelid margin: a transitional zone for 2 epithelial phenotypes. Arch Ophthalmol. 2007;125:523-532. (Pubitemid 46596725)
21. El Karim IA, Lamey PJ, Ardill J, et al. Vasoactive intestinal polypeptide (VIP) and VPAC1 receptor in adult human dental pulp in relation to caries. Arch Oral Biol. 2006;51:849-855. (Pubitemid 44373848)
22. Tachibana T, Nawa T. Immunohistochemical reactions of receptors to met-enkephalin, VIP, substance P, and CGRP located on Merkel cells in the rat sinus hair follicle. Arch Histol Cytol. 2005;68:383-391.
23. Yamaza T, Kido MA, Wang B, et al. Distribution of substance P and neurokinin-1 receptors in the peri-implant epithelium around titanium dental implants in rats. Cell Tissue Res. 2009;335:407-415.
24. Lessard A, Pickel VM. Subcellular distribution and plasticity of neurokinin-1 receptors in the rat substantia nigra and ventral tegmental area. Neuroscience. 2005;135:1309-1323. (Pubitemid 41416691)
25. Enŕiquez de Salamanca A, Siemasko KF, Diebold Y, et al. Expression of muscarinic and adrenergic receptors in normal human conjunctival epithelium. Invest Ophthalmol Vis Sci. 2005;46:504-513. (Pubitemid 40270328)
26. Lind GJ, Cavanagh HD. Nuclear muscarinic acetylcholine receptors in corneal cells from rabbit. Invest Ophthalmol Vis Sci. 1993;34:2943-2951.
27. Colley AM, Cavanagh HD, Law ML. Subcellular localization of muscarinic effects on enzymes of cyclic nucleotide metabolism in cultured corneal cells of the rabbit. Metab Pediatr Syst Ophthalmol. 1987; 10:36-38.
28. Colley AM, Law ML. Effects of carbamylcholine on nuclear cyclic-nucleotide-dependent protein kinase activity in cultured corneal epithelial cells of the rabbit. Metab Pediatr Syst Ophthalmol. 1987;10:24-31.
29. Colley AM, Cavanagh HD, Drake LA, et al. Cyclic nucleotides in muscarinic regulation of DNA and RNA polymerase activity in cultured corneal epithelial cells of the rabbit. Curr Eye Res. 1985;4:941-950.
30. Cavanagh HD, Colley AM. The molecular basis of neurotrophic keratitis. Acta Ophthalmol Suppl. 1989;192:115-134.
31. Curtis CA, Wheatley M, Bansal S, et al. Propylbenzilylcholine mustard labels an acidic residue in transmembrane helix 3 of the muscarinic receptor. J Biol Chem. 1989;264:489-495. (Pubitemid 19027630)
32. Leach KL, Powers EA, Ruff VA, et al. Type 3 protein kinase C localization to the nuclear envelope of phorbol ester-treated NIH 3T3 cells. J Cell Biol. 1989;109:685-695.
33. LeDoux MS, Zhou Q, Murphy RB, et al. Parasympathetic innervation of the meibomian glands in rats. Invest Ophthalmol Vis Sci. 2001;42:2434-2441. (Pubitemid 32954845)
34. Catalani E, Gangitano C, Bosco L, et al. Expression of the neurokinin 1 receptor in the mouse retina. Neuroscience. 2004;128:519-530 (Pubitemid 39277422)
35. Murabayashi H, Kuramoto H, Kawano H, et al. Immunohistochemical features of substance P-immunoreactive chromaffin cells and nerve fibers in the rat adrenal gland. Arch Histol Cytol. 2007;70:183-196. (Pubitemid 350224154)
36. Choi JY, Khansaheb M, Joo NS, et al. Substance P stimulates human airway submucosal gland secretion mainly via a CFTR-dependent process. J Clin Invest. 2009;119:1189-1200.
37. Valiante S, Prisco M, Sciarrillo R, et al. Pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors: distribution and involvement in the secretion of Podarcis sicula adrenal gland. J Endocrinol. 2008;196:291-303. (Pubitemid 351298514)
38. Choi JY, Joo NS, Krouse ME, et al. Synergistic airway gland mucus secretion in response to vasoactive intestinal peptide and carbachol is lost in cystic fibrosis. J Clin Invest. 2007;117:3118-3127.
39. Dartt DA. Signal transduction and control of lacrimal gland protein secretion: a review. Curr Eye Res. 1989;8:619-636. (Pubitemid 19160725)
40. Hodges RR, Zoukhri D, Lightman JP, et al. Identification and cellular localization of the components of the VIP signaling pathway in the lacrimal gland. Adv Exp Med Biol. 1998;438:169-176. (Pubitemid 28303734)
41. Hodges RR, Zoukhri D, Sergheraert C, et al. Identification of vasoactive intestinal peptide receptor subtypes in the lacrimal gland and their signal-transducing components. Invest Ophthalmol Vis Sci. 1997;38:610-619. (Pubitemid 27143131)
42. Rao NV, Macchi C, Tortorella C, et al. Neuropeptide Yand glucocorticoid secretion from guinea pig adrenal gland: an in vivo and in vitro study. Int J Mol Med. 2007;20:345-349.
43. Leblanc GG, Landis SC. Target specificity of neuropeptide Y-immuno-reactive cranial parasympathetic neurons. J Neurosci. 1988;8:146-155.
44. Adeghate EA, Singh J, Howarth FC, et al. Control of porcine lacrimal gland secretion by non-cholinergic, non-adrenergic nerves: effects of electrical field stimulation, VIP and NPY. Brain Res. 1997;758:127-135. (Pubitemid 27310650)
45. Seifert P, Stuppi S, Spitznas M, et al. Differential distribution of neuronal markers and neuropeptides in the human lacrimal gland. Graefes Arch Clin Exp Ophthalmol. 1996;234:232-240. (Pubitemid 26097963)
46. Adeghate E. Pattern of distribution of neuropeptides in the camel lacrimal gland. Neuropeptides. 1996;30:566-571. (Pubitemid 27013983)
47. Galvin RJ, Babbey LE, Hipskind PA, et al. Substance P regulates PTH secretion through the neurokinin-1 receptor. Biochem Biophys Res Commun. 2000;270:230-234.
48. Huleux C, Berthier A, Rossignol B, et al. A "septide- sensitive''receptor is not involved in tachykinin-mediated secretory and inositol phosphate responses in rat parotid gland: are several transduction pathways involved after the stimulation of the NK1 receptor? J Neurochem. 1998;70: 858-864. (Pubitemid 28079378)
49. Wagner U, Fehmann HC, Bredenbroker D, et al. Effects of selective tachykinin-receptor antagonists on tachykinin-induced airway mucus secretion in the rat. Neuropeptides. 1999;33:55-61. (Pubitemid 29248965)
50. Rogers DF, Aursudkij B, Barnes PJ. Effects of tachykinins on mucus secretion in human bronchi in vitro. Eur J Pharmacol. 1989;174:283-286. (Pubitemid 20029409)
51. Piedimonte G. Tachykinin peptides, receptors and peptidases in airway disease. Exp Lung Res. 1995;21:809-834.
52. Phillips JE, Hey JA, Corboz MR. Tachykinin NK3 and NK1 receptor activation elicits secretion from porcine airway submucosal glands. Br J Pharmacol. 2003;138:254-260.
53. Mikkelsen JD, Hauser F, Olcese J. Neuropeptide Y (NPY) and NPY receptors in the rat pineal gland. Adv Exp Med Biol. 1999;460: 95-107. (Pubitemid 32195046)
54. Simonneaux V, Ouichou A, Craft C, et al. Presynaptic and postsynaptic effects of neuropeptide Y in the rat pineal gland. J Neurochem. 1994;62: 2464-2471. (Pubitemid 24179531)
55. McCloskey MJ, Potter EK. Sympathetic and parasympathetic interaction in vascular and secretory control of salivary glands in anaesthetised dogs. Auton Neurosci. 2000;84:50-57.
56. Spinazzi R, Andreis PG, Nussdorfer GG. Neuropeptide-Yand Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions. Int J Mol Med. 2005;15:3-13.
57. Bewley MS, Pena JT, Plesch FN, et al. Shark rectal gland vasoactive intestinal peptide receptor: cloning, functional expression, and regulation of CFTR chloride channels. Am J Physiol Regul Integr Comp Physiol. 2006;291:R1157-R1164.
58. Chaiseha Y, Youngren OM, El Halawani ME. Expression of vasoactive intestinal peptide receptor messenger RNA in the hypothalamus and pituitary throughout the turkey reproductive cycle. Biol Reprod. 2004;70: 593-599. (Pubitemid 38233695)
59. Tobin G. Muscarinic receptor subtypes in the submandibular gland and the urinary bladder of the rabbit: in vivo and in vitro functional comparisons of receptor antagonists. J Auton Pharmacol. 1995;15: 451-463. (Pubitemid 26106369)
60. Tobin G, Giglio D, Götrick B. Studies of muscarinic receptor subtypes in salivary gland function in anaesthetized rats. Auton Neurosci. 2002;100: 1-9.
61. Tobin G, Ryberg AT, Gentle S, et al. Distribution and function of muscarinic receptor subtypes in the ovine submandibular gland. J Appl Physiol. 2006;100:1215-1223. (Pubitemid 43671479)
62. 2 channels on the luminal membrane of lacrimal acinar cells. Proc Natl Acad Sci USA. 1992;89:11229-11233.
63. Ŕios JD, Zoukhri D, Rawe IM, et al. Immnunolocalization of muscarinic and VIP receptor subtypes and their role in stimulating goblet cell secretion. Invest Ophthalmol Vis Sci. 1999;40:1102-1111. (Pubitemid 29211447)
64. Kessler TL, Mercer HJ, Zieske JD, et al. Stimulation of goblet cell mucous secretion by activation of nerves in rat conjunctiva. Curr Eye Res. 1995; 14:985-992.
65. Ŕios JD, Forde K, Diebold Y, et al. Development of conjunctival goblet cells and their neuroreceptor subtype expression. Invest Ophthalmol Vis Sci. 2000;41:2127-2137. (Pubitemid 30450984)
66. Dartt DA. Regulation of mucin and fluid secretion by conjunctival epithelial cells. Prog Retin Eye Res. 2002;21:555-576. (Pubitemid 35341511)
67. Jumblatt JE, Jumblat MM. Detection and quantification of conjunctival mucins. Adv Exp Med Biol. 1998;438:239-246.
68. Eglen RM, Choppin A, Dillon MP, et al. Muscarinic receptor ligands and their therapeutic potential. Curr Opin Chem Biol. 1999;3:426-432. (Pubitemid 29376104)